Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Repligen Corporation |
---|---|
Information provided by: | Repligen Corporation |
ClinicalTrials.gov Identifier: | NCT00660335 |
The purpose of this study is to evaluate the safety and effectiveness of RG1068 (synthetic human secretin) with MRCP in subjects with abnormalities of the pancreas.
Condition | Intervention | Phase |
---|---|---|
Pancreatitis |
Drug: RG1068 (synthetic human secretin) |
Phase III |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Single Group Assignment, Efficacy Study |
Official Title: | Phase III Study to Demonstrate the Efficacy and Safety of RG1068 (Synthetic Human Secretin)- Enhanced Magnetic Resonance Cholangiopancreatography (MRCP) in the Evaluation of Subjects With a History of Acute or Acute Recurrent Pancreatitis |
Estimated Enrollment: | 270 |
Study Start Date: | March 2008 |
Estimated Study Completion Date: | September 2009 |
Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Drug: RG1068 (synthetic human secretin)
Single-dose, IV infusion
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Repligen Corporation ( Melinda Livingstone ) |
Study ID Numbers: | RG1068-16 |
Study First Received: | April 15, 2008 |
Last Updated: | January 29, 2009 |
ClinicalTrials.gov Identifier: | NCT00660335 History of Changes |
Health Authority: | United States: Food and Drug Administration; Canada: Health Canada |
secretin, RG1068, MRCP, pancreas |
Secretin Digestive System Diseases Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Pancreatic Diseases Congenital Abnormalities |
Hormones Pancrelipase Recurrence Pancreatitis Pancreatitis, Chronic |
Secretin Digestive System Diseases Therapeutic Uses Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists |
Gastrointestinal Agents Pancreatic Diseases Hormones Pharmacologic Actions Pancreatitis |